Farrokh Modabber
-
- Research on Leishmaniasis Studies 46
- Parasitology top 1%
- Parasites and Host Interactions 6
- Epidemiology top 1%
- Trypanosoma species research and implications 20
- Immunology top 5%
- Immunotherapy and Immune Responses 4
- Infectious Diseases top 5%
- Leprosy Research and Treatment 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Ali KhamesipourYahya DowlatiIraj SharifiSassan NoazinEltahir Awad Gasim KhalilPeter G. SmithFábio ZickerPiero Olliaro
- Journals
- Infection and Immunity (6 papers)Vaccine (6 papers)Transactions of the Royal Society of Tropical Medicine and Hygiene (6 papers)
- Partner nations
- SwitzerlandUnited StatesIran
In The Last Decade
Farrokh Modabber
68 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 93
- Public Health, Environmental and Occupational Health 3.0k
- Parasitology 537
- Epidemiology 1.8k
- Immunology 722
- Infectious Diseases 337
Countries citing papers authored by Farrokh Modabber
This map shows the geographic impact of Farrokh Modabber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farrokh Modabber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farrokh Modabber more than expected).
Fields of papers citing papers by Farrokh Modabber
This network shows the impact of papers produced by Farrokh Modabber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farrokh Modabber. The network helps show where Farrokh Modabber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Farrokh Modabber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 21 | |
| 2 | 2015 | 78 | |
| 3 | 2011 | 239 | |
| 4 | 2010 | 66 | |
| 5 | 2010 | 42 | |
| 6 | 2009 | 33 | |
| 7 | 2008 | 138 | |
| 8 | 2005 | 78 | |
| 9 | 2003 | 48 | |
| 10 | 2003 | 41 | |
| 11 | 2002 | 76 | |
| 12 | 2000 | 200 | |
| 13 | 2000 | 41 | |
| 14 | 1999 | 131 | |
| 15 | 1997 | 42 | |
| 16 | 1996 | 49 | |
| 17 | Vaccine: the only hope to control leishmaniasis. | 1996 | 4 |
| 18 | 1989 | 78 | |
| 19 | 1987 | 9 | |
| 20 | Characterization of T and B antigen-binding cells for beta-galactosidase. I. beta-galactosidase-binding cells in the thymus and spleen of normal mice. | 1976 | 1 |
About Farrokh Modabber
Farrokh Modabber is a scholar working on Public Health, Environmental and Occupational Health, Parasitology, Epidemiology, Immunology and Infectious Diseases, having authored 71 papers that have together received 3.5k indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (46 papers), Trypanosoma species research and implications (20 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Parasites and Host Interactions (6 papers), Immunotherapy and Immune Responses (4 papers), Leprosy Research and Treatment (4 papers), Glycosylation and Glycoproteins Research (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (3.0k citations), Parasitology (537 citations), Epidemiology (1.8k citations), Immunology (722 citations) and Infectious Diseases (337 citations). Farrokh Modabber has collaborated with scholars based in Switzerland, United States and Iran. Frequent co-authors include Ali Khamesipour, Yahya Dowlati, Iraj Sharifi, Sassan Noazin, Eltahir Awad Gasim Khalil, Peter G. Smith, Fábio Zicker, Piero Olliaro, Sima Rafati and R. Hashemi‐Fesharki. Their work appears in journals such as Infection and Immunity, Vaccine, Transactions of the Royal Society of Tropical Medicine and Hygiene, The Journal of Immunology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.